Drug Company Nemesis Strikes Again Crusading cardiologist took on Vioxx, now Avandia, for heart risks By Sam Gale Rosen Posted May 22, 2007 1:32 PM CDT Copied Steven Nissen, M.D. poses at the 56th Annual American College of Cardiology Conference Scientific session in New Orleans, Monday, March 26, 2007. (AP Photo/Judi Bottoni) (Associated Press) The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. Nissen's study is a meta-analysis of data from earlier studies on Avandia he found with a Google search. The results of other studies had been posted by the company, GlaxoSmithKline, itself, after earlier accusations that it withheld negative information. The FDA is not taking action on the drug until it completes its own analysis. Read These Next Elon Musk just reached a major money milestone. Skydivers remarkably survive after both parachutes fail. Ex-political candidate mired in sex tape scandal now has legal woes. Bad news for the famous 'Nirvana baby.' Report an error